Physician
Granger Medical Clinic PC
Granger Medical Clinic PC was paid $5.05M by Medicaid between Jan 2018 and Dec 2024, across 150 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoGRANGER MEDICAL CLINIC PC
WEST VALLEY CITY, UT 84119
WEST VALLEY CITY, UT 84119
33aNPI1184657041assigned 07/07/2006
33bProvider typeOrthopaedic Surgery Physician
28Total paid$5.05M
24GClaims201,717
24DCodes billed150
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Orthopaedic Surgery Physician providers in Utah
Rank by total paid#1 of 31
Median peer was paid$15K
This provider vs. median340×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,268 | $478K | |
| 2019 | 20,811 | $584K | |
| 2020 | 19,334 | $418K | |
| 2021 | 40,830 | $983K | |
| 2022 | 37,995 | $1.01M | |
| 2023 | 28,791 | $652K | |
| 2024incomplete | 36,688 | $929K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 25,652 | 22,715 | $1.48M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 26,878 | 23,949 | $1.31M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.0% | 5,928 | 5,211 | $454K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.0% | 5,034 | 4,795 | $405K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.5% | 4,176 | 3,739 | $227K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.0% | 2,535 | 2,348 | $154K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.8% | 1,253 | 1,144 | $142K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 1,966 | 1,905 | $95K |
| 80050 | General health panel | 1.4% | 1,580 | 1,403 | $68K |
| 80053 | Comprehensive metabolic panel | 1.3% | 4,510 | 4,060 | $68K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14,554 | 13,524 | $40K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 846 | 780 | $39K |
138 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 979 | $35K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 777 | $31K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 591 | $30K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,562 | $29K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,982 | $28K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 12 | $24K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,796 | $20K |
| 80061 | Lipid panel | <1% | 3,007 | $19K |
| 90461 | <1% | 1,834 | $18K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 553 | $16K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 234 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,760 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,382 | $12K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 7,139 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,187 | $11K |
| 99381 | <1% | 143 | $10K | |
| 99493 | <1% | 111 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,403 | $10K |
| 99245 | <1% | 60 | $9K | |
| 87806 | <1% | 333 | $9K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 118 | $9K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 111 | $8K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 201 | $8K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 42 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 682 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 577 | $7K |
| 82728 | <1% | 480 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 117 | $6K |
| 83013 | <1% | 98 | $6K | |
| 91320 | <1% | 61 | $6K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 210 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 336 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 110 | $5K |
| 64483 | <1% | 36 | $5K | |
| 82043 | <1% | 496 | $5K | |
| 90677 | <1% | 759 | $5K | |
| 87081 | <1% | 1,362 | $5K | |
| 82950 | <1% | 574 | $5K | |
| 90651 | <1% | 527 | $4K | |
| 84439 | <1% | 737 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 92 | $4K |
| 82247 | <1% | 393 | $4K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 77 | $4K |
| 90715 | <1% | 351 | $4K | |
| 95117 | <1% | 456 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 82 | $3K |
| 90686 | <1% | 5,312 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 20 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 512 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,712 | $3K |
| 99494 | <1% | 62 | $3K | |
| 99000 | <1% | 1,781 | $3K | |
| 99173 | <1% | 6,028 | $2K | |
| 96127 | <1% | 1,073 | $2K | |
| 95115 | <1% | 305 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 687 | $2K |
| 81003 | <1% | 2,068 | $2K | |
| 81001 | <1% | 186 | $2K | |
| 84702 | <1% | 229 | $2K | |
| 83550 | <1% | 642 | $2K | |
| 83540 | <1% | 680 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,640 | $2K |
| 52000 | <1% | 16 | $2K | |
| 90656 | <1% | 359 | $1K | |
| 90480 | <1% | 62 | $1K | |
| 94010 | <1% | 75 | $1K | |
| 85651 | <1% | 438 | $1K | |
| 84153 | <1% | 89 | $1K | |
| 36416 | <1% | 880 | $1K | |
| 99459 | <1% | 100 | $938.36 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 12 | $904.50 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 143 | $862.72 |
| 99152 | <1% | 142 | $822.37 | |
| 73562 | <1% | 84 | $784.80 | |
| 73630 | <1% | 77 | $726.55 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12 | $722.14 |
| 90688 | <1% | 280 | $721.88 | |
| 83014 | <1% | 98 | $607.29 | |
| 82570 | <1% | 483 | $602.77 | |
| 82248 | <1% | 377 | $580.89 | |
| 92015 | Determination of refractive state | <1% | 1,039 | $565.48 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $552.37 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $552.37 |
| 90716 | <1% | 215 | $530.36 | |
| 74018 | <1% | 50 | $513.81 | |
| 90673 | <1% | 14 | $506.49 | |
| 90734 | <1% | 359 | $494.25 | |
| 99385 | <1% | 13 | $490.10 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 21 | $470.72 |
| 90648 | <1% | 4,331 | $436.81 | |
| 99201 | <1% | 29 | $434.39 | |
| 20610 | <1% | 14 | $418.69 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 27 | $390.62 |
| 81000 | <1% | 135 | $357.40 | |
| 99382 | <1% | 12 | $337.20 | |
| 94760 | <1% | 1,546 | $282.68 | |
| 86140 | <1% | 77 | $272.33 | |
| 90707 | <1% | 235 | $268.92 | |
| 51798 | <1% | 98 | $261.35 | |
| 85652 | <1% | 89 | $245.53 | |
| 85018 | <1% | 195 | $240.86 | |
| 84403 | <1% | 15 | $232.50 | |
| 90658 | <1% | 18 | $199.17 | |
| 83001 | <1% | 18 | $194.00 | |
| 90620 | <1% | 58 | $191.75 | |
| 99383 | <1% | 12 | $184.02 | |
| 83690 | <1% | 192 | $181.08 | |
| 81015 | <1% | 33 | $176.10 | |
| 90670 | <1% | 3,591 | $171.31 | |
| 74019 | <1% | 13 | $159.30 | |
| 94762 | <1% | 27 | $151.73 | |
| 73610 | <1% | 17 | $139.59 | |
| 86580 | <1% | 14 | $107.66 | |
| 90680 | <1% | 1,914 | $95.96 | |
| 82607 | <1% | 108 | $93.41 | |
| 90723 | <1% | 2,711 | $92.63 | |
| 90662 | <1% | 29 | $70.00 | |
| 84550 | <1% | 27 | $48.92 | |
| 90633 | <1% | 831 | $37.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 56 | $31.69 |
| G0008 | Administration of influenza virus vaccine | <1% | 104 | $19.80 |
| 90696 | <1% | 240 | $0.02 | |
| 90700 | <1% | 133 | $0.01 | |
| 90474 | 0% | 956 | $0.00 | |
| 99024 | 0% | 326 | $0.00 | |
| 91307 | 0% | 17 | $0.00 | |
| A4215 | Needle, sterile, any size, each | 0% | 208 | $0.00 |
| 99070 | 0% | 177 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 13 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 13 | $0.00 |
| 83735 | 0% | 14 | $0.00 | |
| 87280 | 0% | 14 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 138 | $0.00 |
| 90710 | 0% | 277 | $0.00 | |
| A4550 | Surgical trays | 0% | 209 | $0.00 |
| 90685 | 0% | 133 | $0.00 | |
| 91300 | 0% | 16 | $0.00 | |
| 80305 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPENNINGTON, MARY JANE (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Granger Medical Specialists LLC | West Valley City, UT | $617K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.